TREATMENT OF RENAL OSTEODYSTROPHY IN CHILDREN WITH 1,25 (OH)2 D3

被引：0
|
作者：
MALEKZADEH, MH
PENNISI, AJ
UITTENBOGAART, CH
ETTENGER, RB
FINE, RN
机构：
[1] UNIV SO CALIF,DEPT PEDIAT,LOS ANGELES,CA 90007
[2] CHILDRENS HOSP,DIV DIALYSIS & TRANSPLANTAT,LOS ANGELES,CA 90027
来源：
CLINICAL RESEARCH | 1980年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [21] LONG-TERM THERAPY WITH 1,25 (OH)2 VITAMIN-D3 (D) IN ADULTS WITH RENAL OSTEODYSTROPHY
    MOORTHY, AV
    HARRINGTON, AR
    SIMPSON, DP
    MAZESS, RB
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 953 - 953
  • [22] 24,25(OH)2D3 IN COMBINATION WITH 1,25(OH)2D3 AMELIORATES RENAL OSTEODYSTROPHY IN RATS WITH CHRONIC RENAL-FAILURE (CRF)
    RUBINGER, D
    MOSCOVITZ, A
    POPOVTZER, MM
    BAB, I
    GAZIT, D
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 379 - 379
  • [23] Pharmacokinetics of 1,25(OH)2D3 and 1α(OH)D3 in normal and uraemic men
    Brandi, L
    Egfjord, M
    Olgaard, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (05) : 829 - 842
  • [24] Effects of vitamin D3, 25(OH)D, and 1,25(OH)2D on calcium absorption efficiency
    Barger-Lux, MJ
    Heaney, RP
    NUTRITIONAL ASPECTS OF OSTEOPOROSIS, 1998, : 229 - 236
  • [25] SYNERGIC EFFECT OF 250HD3 AND 1,25(OH)2D3 IN RENAL OSTEODYSTROPHY IS UNRELATED TO 24,25(OH)2D3 LEVELS
    COEN, G
    GALLUCCI, T
    BONUCCI, E
    BALLANTI, P
    MATTEUCCI, MC
    BIANCHI, AR
    BIANCHINI, G
    PICCA, S
    CINOTTI, GA
    CASCIANI, CU
    ARTIFICIAL ORGANS, 1981, 5 (02) : 193 - 193
  • [26] MANAGEMENT OF RENAL OSTEODYSTROPHY WITH 1,25(OH)2D3 .1. EFFECTS ON CLINICAL, RADIOGRAPHIC AND BIOCHEMICAL PARAMETERS
    GOLDSTEIN, DA
    MALLUCHE, HH
    MASSRY, SG
    MINERAL AND ELECTROLYTE METABOLISM, 1979, 2 (01) : 35 - 47
  • [27] VITAMIN-D METABOLITE PROFILES (MP) AFTER TREATMENT (RX) OF MODERATE CHILDHOOD RENAL-INSUFFICIENCY (RI) WITH 25 (OH)D3 (25D) AND 1,25(OH)2D (1,25D)
    NORMAN, M
    TAYLOR, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 1986, 1 (01) : 149 - 149
  • [28] RENAL OSTEODYSTROPHY IN CHILDREN TREATED WITH 1,25-DIHYDROXY-CHOLECALCIFEROL [1,25-(OH)2D3] - HISTOLOGIC BONE STUDIES
    ROBITAILLE, P
    MARIE, PJ
    DEVLIN, EE
    LORTIE, L
    GLORIEUX, FH
    ACTA PAEDIATRICA SCANDINAVICA, 1984, 73 (03): : 315 - 324
  • [29] EFFECT OF PTH AND 1,25(OH)2D3 ON RENAL 25(OH)D3 METABOLISM, ADENYLATE-CYCLASE, AND PROTEIN-KINASE
    ARMBRECHT, HJ
    WONGSURAWAT, N
    ZENSER, TV
    DAVIS, BB
    AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (01): : E102 - E107
  • [30] INHIBITION OF THE ANTIPHOSPHATURIC ACTIONS OF 25(OH)VITAMIN D3 AND 1,25(OH)2 VITAMIN-D3 BY CYCLOHEXIMIDE
    BREZIS, M
    POPOVTZER, MM
    CLINICAL RESEARCH, 1980, 28 (02): : A387 - A387
12345